STOCKS | Hong Kong's Innovative Drug Sector Declines

Hong Kong's innovative drug sector continues to experience a downturn, with Zai Lab (09688.HK) dropping over 6% and Jiangsu Hengrui Medicine (01276.HK) falling more than 4%. According to Jin10, other companies such as CSPC Pharmaceutical Group (01093.HK) and WuXi AppTec (02359.HK) also saw declines.